UPS to acquire Australian healthcare specialist Smartway Logistics
UPS (NYSE: UPS) agreed to acquire Smartway Logistics, a healthcare logistics provider in Australia and New Zealand, for $405 million. The deal, expected to close in 2027, aims to expand UPS's healthcare capabilities in the Asia-Pacific region. UPS reported $3 billion in healthcare revenue for the third quarter, with a projected annual run rate of over $12 billion. Smartway specializes in time-critical courier services for the healthcare sector.
How this was made

The 30-second read
Why it matters
The Smartways acquisition adds same-day/next-day healthcare courier and contract logistics capacity in Australia and New Zealand, and connects Smartways customers to UPS’s global network for international shipping.
Market read
Traders may reassess UPS’s healthcare growth trajectory and integration pipeline following a new acquisition agreement with a 2027 close target.
What to watch
Healthcare logistics growth assumptions may not translate into UPS margins if pricing competition intensifies or if regulatory and operational requirements for clinical trials and radiopharmaceutical handling raise costs.
Background
UPS is reorganizing around higher-margin industry verticals and has been making prior healthcare logistics acquisitions (e.g., Andlauer Healthcare Group) to build cold-chain and time-critical capabilities.
Ticker impact
UPS agreed to acquire Smartways Logistics, expanding healthcare time-critical courier capabilities in Australia and New Zealand, with close expected in H1 2027.
Likely positive bias as investors price in growth optionality from healthcare logistics and network integration, tempered by undisclosed deal terms and execution risk.
The article discloses a new acquisition agreement, expected close timing, and strategic rationale (healthcare logistics growth, healthcare revenue run-rate), but provides no purchase price or financial terms beyond a reported offer figure.
Market effects
Reinforces consolidation and vertical specialization in healthcare logistics, highlighting cold-chain and time-critical delivery as a growth battleground.
Could increase competitive pressure for healthcare courier and contract logistics providers in Australia and New Zealand as UPS extends its Oceania footprint.
Strengthens UPS’s end-to-end international shipping proposition for healthcare customers, potentially affecting cross-border logistics demand patterns.
Counterpoint
Undisclosed deal economics and integration complexity could limit near-term earnings accretion, making the market reaction more sentiment-driven than fundamentals-driven.
Key entities
- public_companyUPS
United Parcel Service, the acquirer expanding UPS Healthcare capabilities in Asia-Pacific/Oceania.
- private_companySmartways Logistics
Australian healthcare logistics provider focused on time-critical courier services for medical devices, life sciences, clinical trials, and radiopharmaceuticals.
- private_equityThe Riverside Company
Private equity owner of Smartways Logistics.




